| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/02/1999 | WO1999043706A1 Derivatives of glp-1 analogs |
| 09/02/1999 | WO1999043705A1 N-terminally truncated glp-1 derivatives |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | WO1999043361A1 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043341A1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043325A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 09/02/1999 | WO1999043310A2 20-hete antagonists and agonists |
| 09/02/1999 | WO1999043220A1 Product and method to reduce stress induced immune suppression |
| 09/02/1999 | WO1999043218A1 Method for producing a fat mixture |
| 09/02/1999 | WO1999043217A1 Use of d-tagatose as a prebiotic food component |
| 09/02/1999 | WO1999033450A3 Pharmaceutical composition containing sibutramine and orlistat |
| 09/02/1999 | WO1999029333A8 Compositions and methods for weight reduction |
| 09/02/1999 | WO1999021540A3 Method of reducing craving in mammals |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2321642A1 N-¬(substituted five-membered di- or triaza diunsaturated ring)carbonyl|guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0938503A1 Insulin c-peptides |
| 09/01/1999 | EP0938480A1 Substituted tetrahydro-1,3,5-triazin-2 1h]-thiones as anti-atherosclerotic agents |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938476A1 Process for substituted pyridines |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938319A1 Pharmaceutical compositions containing alendronate and an agent promoting gastric emptying |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0828497B1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 09/01/1999 | EP0808111B1 A low phosphorus animal feed containing 1 -alpha- hydroxylated vitamin d compounds |
| 09/01/1999 | EP0764174B1 Process for removing bile salts from a patient and alkylated compositions therefor |
| 09/01/1999 | CN1227567A Exendin analogues, processes for their preparation and medicaments containing them |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227552A Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 09/01/1999 | CN1227538A Pharmaceutical composition containing 4-oxo-butynic acid |
| 09/01/1999 | CN1227501A Long-acting drugs and pharmaceutical compositions comprising them |
| 09/01/1999 | CN1227496A Screening method for compounds useful in the regulation of body weight |
| 09/01/1999 | CN1227495A Compositions of plant carbohydrates as dietary supplements |
| 09/01/1999 | CN1227487A Pharmaceutical compositions containing mesembrine and related compounds |
| 09/01/1999 | CN1044912C Thio-substituted cyclic phosphonate compounds, and its pharmaceutical compositions and use |
| 09/01/1999 | CN1044910C Indole derivatives |
| 09/01/1999 | CN1044909C 吲哚衍生物 Indole derivatives |
| 08/31/1999 | USRE36288 Mixture of protein, lipid and carbohydrates |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945455 Amine and amidine containing compounds as weight reducing agents |
| 08/31/1999 | US5945446 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 08/31/1999 | US5945401 Polypeptides as antidiabetic agents |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945330 Polynucleotide |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/31/1999 | US5945129 Process for the production of an infusion or dialysis solution containing bicarbonate |
| 08/31/1999 | US5945107 Compositions and methods for weight reduction |
| 08/31/1999 | CA2173147C Anti-obesity agent |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042601A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 08/26/1999 | WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042482A1 Methods for treatment of diabetes using peptide analogues of insulin |
| 08/26/1999 | WO1999042465A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 08/26/1999 | WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 08/26/1999 | WO1999042427A1 E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
| 08/26/1999 | WO1999042127A2 Receptor derived peptides as modulators of receptor activity |
| 08/26/1999 | WO1999042089A2 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 08/26/1999 | WO1999042001A1 Calorically dense nutritional composition |
| 08/26/1999 | WO1999033825A8 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them |
| 08/26/1999 | WO1999024421A8 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/26/1999 | WO1998004693A3 Secreted proteins and polynucleotides encoding them |
| 08/26/1999 | DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction |
| 08/26/1999 | CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 08/26/1999 | CA2322200A1 Receptor derived peptides as modulators of receptor activity |
| 08/26/1999 | CA2321929A1 Methods for treatment of diabetes using peptide analogues of insulin |
| 08/26/1999 | CA2321278A1 Novel compounds |
| 08/26/1999 | CA2321052A1 Process for the obtaining of hmg-coa reductase inhibitors of high purity |
| 08/26/1999 | CA2318237A1 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937145A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
| 08/25/1999 | EP0937085A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 08/25/1999 | EP0937077A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 08/25/1999 | EP0937065A1 Constrained somatostatin agonists and antagonists |
| 08/25/1999 | EP0937063A1 Aryloxypropanolamine derivatives, method of preparation and applications thereof |
| 08/25/1999 | EP0937054A1 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 08/25/1999 | EP0937046A2 Substituted 3-benzylpyrazoles and their use as herbicides and for lowering the sugar content in blood |
| 08/25/1999 | EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 08/25/1999 | EP0937040A2 N-substituted 2-cyanopyrrolidines |
| 08/25/1999 | EP0937037A1 Sodium salt of poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 08/25/1999 | EP0936913A1 Oral pharmaceutical preparation containing ibandronat |
| 08/25/1999 | EP0751934B1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 08/25/1999 | EP0749430B1 Thiazolidinedione derivatives as anti-hyperglycemic agents |
| 08/25/1999 | EP0602211B1 Use of growth factor igf-ii for the treatment of gastrointestinal disorders |
| 08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
| 08/25/1999 | CN1226831A Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 08/24/1999 | US5942631 Inhibitors of cholesterol esterase |
| 08/24/1999 | US5942550 Cholesterol lowering drink mix compositions |
| 08/24/1999 | US5942549 Improving glucose tolerance |
| 08/24/1999 | US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof |
| 08/24/1999 | US5942524 Serotonin(5-ht-1) agonists |
| 08/24/1999 | US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia |
| 08/24/1999 | US5942502 Method of treating diseases resulting from calcium metabolism disorders |
| 08/24/1999 | US5942497 Purine compound and catecholamine compound containing compositions and methods for administration |